Founder of Gero and physicist in drug discovery land.
Peter Fedichev is a scientist and biotech entrepreneur. His scientific background lies in the field of condensed matter physics, biophysics and bioinformatics. Peter earned M.S. in theoretical physics from the Moscow Institute of Physics and Technology and Ph.D. from the University of Amsterdam. He conducted research at Kurchatov Institute, one of the leading science government agencies in Russia, FOM Institute AMOLF (Netherlands), Moscow University of Physics and Technology, and the University of Innsbruck. To date, he has published over 70 papers in peer-reviewed journals covering his research on physics, biophysics and aging biology.
Peter is a founder of Gero, a data-driven longevity startup focused on developing therapies that will strongly extend a healthy human lifespan.
Visit website: https://gero.ai/team
See also: Gero - AI-powered platform for drug discovery and drug repurposing for age-related diseases.
Peter Fedichev Blog Posts
Highlights of Ending Age-Related Diseases 2020
10-Sep-2020 Key points from 20 presentations from world-leading researchers
Peter Fedichev News
Inheritance of damaging mutations decides how long we get to live
GEN News - 10-Apr-2020
With whole exome and genome sequencing we could reveal so many secrets of lifeRead more...